Ticker brief

MLYS MINERALYS THERAPEUTICS INC

Consumer, Non-cyclical · Biotechnology

last close
$20.55
1 day
-4.3%
14 days
-12.1%
mkt cap
$2.4B
signals 14d
6
authors 14d
4
crowd 14d
-1.9σ
Options inteloptions-surface reads · latest available day per source
metricreadingcontext
IV — ATM 30d48%IV/HV 0.83× (as of 2026-08-26)
Skew — 25Δ RR 30d+0.34325Δ call IV − put IV
Net dealer OI (NDOI)+0.20 elevated5-session Δ +2.29 (as of 2026-05-27)
OI alarmquietlast alarm 2026-06-05 (z=2.4)
Sentiment — last 14 days
daily mean sentiment, 2026-10-02 → 2026-10-11 · now +0.00 (−1 bearish … +1 bullish)
Who spoke4
authorgradetrader scoresignalsmean sent
@OzmosiHealthC·2+0.05
@BiopharmIQB·2+0.00
@PrismMarketViewC·1+0.00
@PersimmonTIA+0.791+0.00
Recent signals6of 6 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-10-11@PersimmonTI+0.00Relays meta-analysis statistics on cardiovascular benefits and renal risks of intensive BP lowering.-12.1%
2026-10-09@OzmosiHealth+0.10Mineralys presented new Lorundrostat data while shares were up 1.54%.-12.1%
2026-10-04@BiopharmIQ+0.00Lists counts of tracked hedge funds holding four Q4-watchlist biotech names.-13.0%
2026-10-04@BiopharmIQ+0.00Lists biotech names with Phase 2 or Phase 3 readouts expected in Q4 2026.-13.0%
2026-10-03@PrismMarketView+0.00Lists named clinical presentations and UNCY's NDA resubmission.-13.0%
2026-10-02@OzmosiHealth+0.00Mineralys announced a presentation of new lorundrostat data at ASN Kidney Week 2026.-13.0%

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.